These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31750766)

  • 1. Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and Inflammation.
    Dragasevic S; Stankovic B; Kotur N; Sokic-Milutinovic A; Milovanovic T; Lukic S; Milosavljevic T; Srzentic Drazilov S; Klaassen K; Pavlovic S; Popovic D
    Metab Syndr Relat Disord; 2020 Feb; 18(1):31-38. PubMed ID: 31750766
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study.
    Dragasevic S; Stankovic B; Sokic-Milutinovic A; Milosavljevic T; Milovanovic T; Lukic S; Drazilov SS; Klaassen K; Kotur N; Pavlovic S; Popovic D
    Clin Immunol; 2018 Dec; 197():86-95. PubMed ID: 30193869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
    Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
    PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
    Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
    Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Koutroumpakis E; Ramos-Rivers C; Regueiro M; Hashash JG; Barrie A; Swoger J; Baidoo L; Schwartz M; Dunn MA; Koutroubakis IE; Binion DG
    Dig Dis Sci; 2016 Mar; 61(3):865-71. PubMed ID: 26514677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients.
    Bsat M; Chapuy L; Rubio M; Wassef R; Richard C; Schwenter F; Loungnarath R; Soucy G; Mehta H; Sarfati M
    Front Immunol; 2019; 10():1177. PubMed ID: 31191543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
    Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
    J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
    Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study.
    Zulian A; Cancello R; Ruocco C; Gentilini D; Di Blasio AM; Danelli P; Micheletto G; Cesana E; Invitti C
    PLoS One; 2013; 8(10):e78495. PubMed ID: 24205244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
    Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
    Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease.
    Bogaert S; Laukens D; Peeters H; Melis L; Olievier K; Boon N; Verbruggen G; Vandesompele J; Elewaut D; De Vos M
    BMC Immunol; 2010 Dec; 11():61. PubMed ID: 21144017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease.
    Morsy Y; Brillant N; Franc Y; Scharl M; Wawrzyniak M; On Behalf Of The Swiss Ibd Cohort Study Group
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944097
    [No Abstract]   [Full Text] [Related]  

  • 18. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.
    Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Piechota-Polańczyk A; Stec-Michalska K; Krajewska WM; Fichna J; Wiśniewska-Jarosińska M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):29-35. PubMed ID: 28338111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
    Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S
    Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.